¼¼°èÀÇ Àΰø¼öÁ¤ ½ÃÀå
Artificial Insemination
»óǰÄÚµå : 1650929
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 194 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Àΰø¼öÁ¤ ¼¼°è ½ÃÀå, 2030³â±îÁö 46¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 30¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â Àΰø¼öÁ¤ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 7.2%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇϸç 2030³â¿¡´Â 46¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Àڱà ³» Àΰø¼öÁ¤Àº CAGR 7.7%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 28¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àڱà ³» Àΰø¼öÁ¤ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 8¾ï 4,000¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 6.7%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ Àΰø¼öÁ¤ ½ÃÀåÀº 2024³â 8¾ï 4,000¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 7¾ï 3,400¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2030³â ºÐ¼® ±â°£ µ¿¾È CAGRÀº 6.7%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 7.0%¿Í 5.8%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è Àΰø¼öÁ¤ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

Àΰø¼öÁ¤ÀÌ ºÒÀÓ Ä¡·á¿¡¼­ Áß¿äÇÑ ¼±ÅÃÀÌ µÇ°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

Àΰø¼öÁ¤(AI)Àº ´Ù¸¥ º¸Á¶»ý½Ä¼ú¿¡ ºñÇØ ´ú ħ½ÀÀûÀ̰í, ´Ù¸¥ º¸Á¶»ý½Ä¼ú¿¡ ºñÇØ ´õ Àú·ÅÇÑ ºñ¿ëÀ¸·Î ºÒÀÓ ¹®Á¦¸¦ °Þ°í ÀÖ´Â Ä¿Çðú °³Àο¡°Ô ¸Å¿ì Áß¿äÇÑ ´ë¾ÈÀ¸·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. ÀÌ ¹æ¹ýÀº ¿©¼ºÀÇ ÀÚ±Ã, ÀڱðæºÎ, ³­°ü¿¡ Á¤ÀÚ¸¦ Á÷Á¢ ÁÖÀÔÇÏ¿© ¼öÁ¤ °¡´É¼ºÀ» ³ôÀÔ´Ï´Ù. ü¿Ü¼öÁ¤(IVF)°ú °°Àº º¹ÀâÇÑ Ä¡·á¿¡ ºñÇØ AI´Â °£´ÜÇϰí ÀÌ¿ëÇϱ⠽¬¿ö ÀÚ¿¬ ÀÓ½ÅÀÌ ¾î·Á¿î »ç¶÷µé¿¡°Ô Àαâ ÀÖ´Â Ä¡·á¹ýÀ¸·Î, °æ¹ÌÇÑ ³²¼º ºÒÀÓ, ¿øÀÎ ºÒ¸íÀÇ ºÒÀÓ, Á¤ÀÚÀÇ À̵¿¼ºÀ» ¹æÇØÇÏ´Â ÀڱðæºÎ Á¡¾× ¹®Á¦°¡ ÀÖ´Â °æ¿ì¿¡ ƯÈ÷ È¿°úÀûÀÔ´Ï´Ù. ¶ÇÇÑ AI´Â µ¿¼º Ä¿ÇÃÀ̳ª µ¶½Å ¿©¼º, Á¤ÀÚ ±âÁõÀ» ¿øÇÏ´Â »ç¶÷µé¿¡°Ôµµ ÇʼöÀûÀÎ ¹æ¹ýÀÔ´Ï´Ù. Ãâ»ê Áö¿¬°ú ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È­·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î ºÒÀÓÀ²ÀÌ Áõ°¡ÇÏ´Â °¡¿îµ¥, Àΰø¼öÁ¤Àº °³Àΰú ºÎºÎ°¡ °¡Á· Çü¼ºÀÇ ¸ñÇ¥¸¦ ´Þ¼ºÇÏ´Â µ¥ ÀÖ¾î Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº Àΰø¼öÁ¤ÀÇ ¼º°ø·üÀ» ¾î¶»°Ô ³ôÀ̰í Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº Àΰø¼öÁ¤ÀÇ È¿°ú¿Í ¼º°ø·üÀ» Å©°Ô Çâ»ó½ÃÄÑ ºÒÀÓ Ä¡·á¸¦ ¿øÇÏ´Â »ç¶÷µé¿¡°Ô ´õ¿í ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼±ÅÃÀÌ µÇ¾ú½À´Ï´Ù. ÷´Ü Á¤ÀÚ ¼±º° ¹æ¹ýÀÇ »ç¿ë°ú Á¤ÀÚ º¸Á¸ ±â¼úÀÇ °³¹ß µî Á¤ÀÚ ¼±º° ¹× Áغñ ±â¼úÀÇ Çõ½ÅÀ¸·Î AI ¹æ¹ý¿¡ »ç¿ëµÇ´Â Á¤ÀÚÀÇ Ç°Áú°ú »ýÁ¸À²ÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ À¯ÀüÀÚ ½ºÅ©¸®´×°ú ¼±º° °úÁ¤ÀÇ ÅëÇÕÀ¸·Î °¡Àå °Ç°­ÇÑ Á¤ÀÚ¸¸ »ç¿ëÇÏ°Ô µÇ¾î Àӽмº°ø °¡´É¼ºÀÌ ´õ¿í ³ô¾ÆÁ³½À´Ï´Ù. ÃÊÀ½ÆÄ À¯µµ Àΰø¼öÁ¤ ±â¼úÀÇ µîÀåÀ¸·Î Á¤ÀÚ ¹èÄ¡ÀÇ Á¤È®µµ°¡ Çâ»óµÇ¾î ¼öÁ¤ °¡´É¼ºÀ» ±Ø´ëÈ­ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ AI¿Í ±â°è ÇнÀÀ» ÅëÇÑ È¯ÀÚ µ¥ÀÌÅÍ ºÐ¼® ¹× Ä¡·á °á°ú ¿¹ÃøÀ» ÅëÇØ ºÒÀÓ Àü¹®Àǰ¡ º¸´Ù È¿°úÀûÀ¸·Î Ä¡·á¸¦ Á¶Á¤ÇÒ ¼ö ÀÖ°Ô µÇ¾î AI¸¦ ÅëÇÑ Àü¹ÝÀûÀÎ ¼º°ø·üÀ» ³ôÀÏ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ºÒÀÓÀ¸·Î ¾î·Á¿òÀ» °Þ°í ÀÖ´Â ¸¹Àº °³Àΰú ºÎºÎ°¡ AI¸¦ ù ¹øÂ° ¼±Åà ġ·á¹ýÀ¸·Î äÅÃÇÏ´Â °ÍÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Àü ¼¼°èÀûÀ¸·Î Àΰø¼öÁ¤ÀÇ Ã¤ÅÃÀ» Çü¼ºÇÏ´Â Ãß¼¼´Â ¹«¾ùÀΰ¡?

»ý½Ä ÀÇ·á ºÐ¾ßÀÇ ±¤¹üÀ§ÇÑ »çȸÀû º¯È­¿Í Áøº¸¸¦ ¹Ý¿µÇÏ¿© ¸î °¡Áö Áß¿äÇÑ Æ®·»µå°¡ Àΰø¼öÁ¤ÀÇ ¼¼°è µµÀÔ¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. Á÷¾÷ÀÇ ¿ì¼±¼øÀ§¿Í ¶óÀÌÇÁ½ºÅ¸ÀÏ ¼±ÅÃÀ¸·Î ÀÎÇØ ºÎ¸ð°¡ µÇ´Â ½Ã±â¸¦ ´ÊÃß´Â °æÇâÀÌ °­È­µÇ¸é¼­ AI¸¦ Æ÷ÇÔÇÑ ºÒÀÓ Ä¡·áÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¶½ÅÀ̳ª µ¿¼º Ä¿ÇÃÀÌ °¡Á¤À» ²Ù¸®´Â °ÍÀÌ »çȸÀûÀ¸·Î ¹Þ¾Æµé¿©Áö¸é¼­ ±âÁõÀÚ Á¤ÀÚ ¼­ºñ½º³ª AI ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á °ü±¤µµ Áß¿äÇÑ Æ®·»µåÀ̸ç, ¸¹Àº °³Àΰú Ä¿ÇõéÀÌ AI¸¦ Æ÷ÇÔÇÑ ºÒÀÓ Ä¡·á¸¦ º¸´Ù ½±°Ô ÀÌ¿ëÇÒ ¼ö Àְųª Àú·ÅÇÑ °¡°ÝÀ¸·Î ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ±¹°¡·Î ¿©ÇàÀ» ¶°³ª°í ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ºÒÀÓ Ä¡·á Ŭ¸®´ÐÀÇ È®´ëµµ AIÀÇ ¼¼°è ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À̵é Áö¿ª¿¡¼­´Â »ý½Ä ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Ã·´Ü ÀÇ·á ÀÎÇÁ¶ó¿¡ ÅõÀÚÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, ºÒÀÓ Ä¡·á¿¡¼­ ¿ø°ÝÀÇ·áÀÇ ÅëÇÕÀº AI¸¦ ´õ¿í Ä£¼÷ÇÏ°Ô ¸¸µé¾î ȯÀÚ°¡ ¿ø°ÝÀ¸·Î Áø·á¸¦ ¹Þ°í Ä¡·á °úÁ¤À» ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°ÔÇÔÀ¸·Î½á AI ¼­ºñ½ºÀÇ µµ´Þ ¹üÀ§¸¦ ³ÐÈ÷°í ÀÖ½À´Ï´Ù.

Àΰø¼öÁ¤ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

Àΰø¼öÁ¤ ½ÃÀåÀÇ ¼ºÀåÀº ºÒÀÓ Ä¡·áÀÇ »óȲÀ» º¯È­½Ã۰í ÀÖ´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È­, ȯ°æÀû ¿äÀÎ, Ãâ»ê Áö¿¬°ú °°Àº Æ®·»µå¿¡ ¿µÇâÀ» ¹ÞÀº Àü ¼¼°è ºÒÀÓ·üÀÇ Áõ°¡¸¦ µé ¼ö ÀÖ½À´Ï´Ù. ±â¼ú ¹ßÀü, ƯÈ÷ Á¤ÀÚ º¸Á¸, À¯ÀüÀÚ °Ë»ç, AI¸¦ ÅëÇÑ È¯ÀÚ °ü¸® µî AI ¼ö¼úÀÇ ¼º°ø·üÀ» ³ôÀÌ°í ´õ ¸¹Àº ȯÀڵ鿡°Ô ¸Å·ÂÀûÀ¸·Î ´Ù°¡°¥ ¼ö ÀÖ´Â ±â¼ú ¹ßÀüÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. AI¿¡ ´ëÇÑ Àνİú Á¢±Ù¼ºÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÅÈï ½ÃÀå¿¡¼­ ºÒÀÓ Ä¡·á ¼­ºñ½ºÀÇ °¡¿ë¼ºÀÌ È®´ëµÇ´Â °Íµµ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¿¼º Ä¿ÇÃ, ¹ÌÈ¥¸ð, ±âÁõÀÚ Á¤ÀÚ¸¦ ã´Â °³ÀεéÀÇ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 AIÀÇ ´ëÀÀ °¡´ÉÇÑ ½ÃÀåÀÌ Å©°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. ºÒÀÓ Ä¡·á¸¦ Áö¿øÇÏ´Â Á¤ºÎ ±ÔÁ¦¿Í º¸Çè Àû¿ëÀº AIÀÇ º¸±ÞÀ» ´õ¿í ÃËÁøÇϰí ÀÖÀ¸¸ç, AI´Â ¸¹Àº »ç¶÷µé¿¡°Ô º¸´Ù Çö½ÇÀûÀ̰í Á¢±ÙÇϱ⠽¬¿î ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼¿¡ µû¶ó Àΰø¼öÁ¤ ½ÃÀåÀº ±â¼ú Çõ½Å, »çȸÀû º¯È­, Á¢±Ù¼º ³ôÀº ºÒÀÓ Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÌ·ê ¼ö ÀÖ´Â ¿©°ÇÀÌ Á¶¼ºµÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

À¯Çü(Àڱó», Àڱðæ°ü³», Áú³», ³­°ü³»), °ø±Þ¿ø À¯Çü(AIH-ºÎºÎ, AID-±âºÎÀÚ), ÃÖÁ¾ ¿ëµµ(ºÒÀÓÄ¡·á¼¾ÅÍ, º´¿ø ¹× Ŭ¸®´Ð, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 41°³»ç ÁÖ¸ñ)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Artificial Insemination Market to Reach US$4.6 Billion by 2030

The global market for Artificial Insemination estimated at US$3.0 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Intrauterine Insemination, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Intracervical Insemination segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$840.0 Million While China is Forecast to Grow at 6.7% CAGR

The Artificial Insemination market in the U.S. is estimated at US$840.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$703.4 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Artificial Insemination Market - Key Trends and Drivers Summarized

Why Is Artificial Insemination Becoming a Crucial Option in Fertility Treatments?

Artificial insemination (AI) has emerged as a pivotal option for couples and individuals facing infertility issues, offering a less invasive and often more affordable alternative to other assisted reproductive technologies. This procedure involves directly introducing sperm into a woman's uterus, cervix, or fallopian tubes, thereby increasing the likelihood of fertilization. The simplicity and accessibility of AI, compared to more complex treatments like in vitro fertilization (IVF), have made it a popular choice for those experiencing difficulties conceiving naturally. AI is particularly beneficial in cases of mild male infertility, unexplained infertility, or cervical mucus issues that impede sperm mobility. Additionally, AI is an essential method for same-sex couples, single women, and those who opt for donor sperm. As infertility rates rise globally due to factors such as delayed childbearing and lifestyle changes, artificial insemination continues to play a vital role in helping individuals and couples achieve their family-building goals.

How Are Technological Advances Enhancing the Success Rates of Artificial Insemination?

Technological advancements have significantly enhanced the effectiveness and success rates of artificial insemination, making it a more reliable option for those seeking fertility treatment. Innovations in sperm selection and preparation techniques, such as the use of advanced sperm sorting methods and the development of sperm preservation technologies, have improved the quality and viability of sperm used in AI procedures. Additionally, the integration of genetic screening and selection processes ensures that only the healthiest sperm are used, further increasing the chances of successful conception. The advent of ultrasound-guided insemination techniques has also improved the precision of sperm placement, maximizing the likelihood of fertilization. Moreover, the use of AI and machine learning in analyzing patient data and predicting outcomes has allowed fertility specialists to tailor treatments more effectively, improving the overall success rates of AI. These technological advancements are driving the adoption of AI as a first-line treatment for many individuals and couples experiencing fertility challenges.

What Trends Are Shaping the Adoption of Artificial Insemination Worldwide?

Several key trends are influencing the adoption of artificial insemination globally, reflecting broader societal changes and advancements in reproductive healthcare. The increasing trend towards delayed parenthood, driven by career priorities and lifestyle choices, has led to a growing need for fertility treatments, including AI. Additionally, the rising social acceptance of single parenthood and same-sex couples seeking to start families has expanded the demand for donor sperm services and AI procedures. Medical tourism is another significant trend, with many individuals and couples traveling to countries where fertility treatments, including AI, are more accessible or affordable. The expansion of fertility clinics in emerging markets is also contributing to the global growth of AI, as these regions invest in advanced healthcare infrastructure to meet the rising demand for reproductive services. Furthermore, the integration of telemedicine in fertility care has made AI more accessible, allowing patients to receive consultations and monitor their treatment progress remotely, thereby broadening the reach of AI services.

What Factors Are Driving the Growth of the Artificial Insemination Market?

The growth in the artificial insemination market is driven by several factors that are reshaping the landscape of fertility treatment. A major driver is the increasing infertility rates worldwide, influenced by factors such as lifestyle changes, environmental factors, and the trend of delayed childbearing. Technological advancements, particularly in sperm preservation, genetic screening, and AI-driven patient management, are enhancing the success rates of AI procedures, making them more appealing to a broader range of patients. The expanding availability of fertility services in emerging markets, coupled with growing awareness and accessibility of AI, is also propelling market growth. Additionally, the rising demand from same-sex couples, single parents, and individuals seeking donor sperm has significantly expanded the addressable market for AI. Government regulations and insurance coverage that support fertility treatments further drive adoption, making AI a more viable and accessible option for many. As these trends continue to evolve, the artificial insemination market is poised for sustained growth, driven by innovation, societal shifts, and increasing demand for accessible fertility solutions.

SCOPE OF STUDY:

The report analyzes the Artificial Insemination market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Intrauterine, Intracervical, Intravaginal, Intratubal); Source Type (AIH-Husband, AID-Donor); End-Use (Fertility Centers, Hospitals & Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â